Straumann
Price
Prix
GRAPH PAR
Dividendes historiques et prévisions
Straumann a jusqu'à présent distribué 0,932 $US en 2024. Le prochain dividende sera payé le 18.04.2025
GRAPH PAR
Questions fréquentes
Quelle est la capitalisation boursière de Straumann ?
Quel est le ratio cours/bénéfice (P/E) de Straumann ?
Quel est le bénéfice par action (BPA) de Straumann ?
Quelles sont les évaluations des analystes et le prix cible de l'action Straumann ?
Quel est le chiffre d'affaires de Straumann sur les douze derniers mois ?
Quel est l'EBITDA de Straumann ?
Quel est le flux de trésorerie disponible de Straumann ?
Combien d'employés compte Straumann, et à quel secteur d'activité appartient-elle ?
Quel est le flottant des actions de Straumann ?
Finances
- Capitalisation boursière
- 20,35 Md $US
- BPA (TTM)
- 1,903 $US
- Free Float
- 107,24 M
- Ratio P/E (TTM)
- 67,05
- Recettes (TTM)
- 2,77 Md $US
- EBITDA (TTM)
- 648,47 M $US
- Cash-flow disponible (TTM)
- 412,40 M $US
Cotation
- 1D span
- 124,66 $US128,15 $US
- 52W span
- 118,29 $US172,61 $US
Notes des analystes
L'objectif de prix est de 152,43 $US et l'action est analysée par 21 analystes.
Acheter
9
Hold
6
Vendre
6
Informations
Straumann Holding AG engages in the provision of implant, restorative, and regenerative dentistry solutions to dental professionals and laboratories. It operates through the following segments: Sales Western Europe, Sales Central Eastern Europe, Middle East and Africa (CEEMEA), Sales North America (NAM), Sales Asia Pacific (APAC), Sales Latin America (LATAM), and Operations. The Sales Western Europe segment comprises Group’s distribution businesses in Scandinavia, the UK, France, the Benelux countries, Iberia and Italy; implant-borne prosthetics business of Createch, as well as Anthogyr manufacturing plants, a French company that develops and manufactures dental implant systems and CADCAM solutions. The Sales CEEMEA segment comprises the Group's distribution businesses mainly in Germany, Switzerland, Austria, Hungary, the Czech Republic, Russia, Turkey, Croatia, Jordan and South Africa, as well as the business with European, African and Middle Eastern distributors. The Sales NAM segment comprises ClearCorrect’s clear-aligner business and its associated development and production activities. The Sales APAC segment comprises Group’s distribution businesses in the Asia pacific region, as well as the business with Asian distributors. The Sales LATAM segment comprises distribution and Instradent businesses in Middle and South America, and Latin America. The Operations segment manufactures plants, implants, and biomaterials. The company was founded by Reinhard Straumann in 1954 and is headquartered in Basel, Switzerland.
- Salariés
- 11 109
- Industries
- Medical Specialties
- Secteur
- Soins de santé
Identifiant
- ISIN
- CH1175448666
- Ticker primaire
- STMN